# Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group

> **NCT00265291** · PHASE2 · COMPLETED · sponsor: **National Institute of General Medical Sciences (NIGMS)** · enrollment: 700 (actual)

## Conditions studied

- Major Depressive Disorder
- Major Depression
- Unipolar Depression

## Interventions

- **DRUG:** fluoxetine or desipramine

## Key facts

- **NCT ID:** NCT00265291
- **Lead sponsor:** National Institute of General Medical Sciences (NIGMS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2006-05
- **Final completion:** 2008-10
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2008-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265291, "Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00265291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*